Nachrichten zur Amgen Inc. Aktie

Prediction: 2 Brilliant Vanguard Index Funds Will Continue to Beat the S&P 500 in 2025

The S&P 500 (SNPINDEX: ^GSPC) is widely considered the best gauge for the overall U.S. stock market due to its…

This Could Be the Best GLP-1 Stock to Buy in 2025

The GLP-1 weight loss market is a massive one, with some analysts expecting it to be worth around $200 billion…

Amgen Stock: Why I Still Rate It A Buy

…

These 3 Dow Jones Stocks Are Crushing It in 2025. Are They Still Buys?

How is the Dow Jones Industrial Average (DJINDICES: ^DJI) performing this year? It might depend on whether you view the…

The Zacks Analyst Blog Highlights AbbVie, Amgen, Stryker, Dexcom and Medtronic

AbbVie, Amgen, Stryker, Dexcom and Medtronic are included in this Analyst Blog.…

Drugmaker Amgen to invest $200 million in India site, CEO says

By Rishika Sadam HYDERABAD, India (Reuters) -U.S. drugmaker Amgen will invest about $200 million this year in its new technology…

Amgen plans $200 million investment in India site, CEO says

U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further…

Amgen to invest $200 million in India site, CEO says

HYDERABAD, India (Reuters) -U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern…

Nebulizer Patent Landscape Report 2024: Innovative Developments Fuel Market Growth

Dublin, Feb. 21, 2025 (GLOBE NEWSWIRE) -- The "Nebulizer Patent Landscape Report" report has been added to …

Amgen, Inc. (AMGN) Citis 2025 Virtual Oncology Leadership Summit Conference (Transcript)

…

This Company Just Initiated a Quarterly Dividend: Time to Buy?

Biotech giant Renegeron Pharmaceuticals (NASDAQ: REGN) reported its fourth-quarter and full-year 2024 earnings on Feb. 4. The companys results were…

Want Decades of Passive Income? Buy This ETF and Hold It Forever.

Who doesnt want passive income? Even Warren Buffett has extolled it, reportedly saying, "If you dont find a way to…

Amgen, Inc. (AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call Transcript

…

Genomic Data Analysis and Interpretation Market Research 2025-2033: Syngenta Group Leads, Followed by Amgen, Monsanto (Bayer), and Illumina

Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The "Genomic Data Analysis and Interpretation Market Opportunities and Strategies to…

Amgens EVP Jonathan Graham sells $7.34 million in stock By Investing.com

Amgens EVP Jonathan Graham sells $7.34 million in stock…

Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move

Investing in stocks that arent performing well can be a good move, but only if there are good reasons to…

Better High-Yield Dividend Stock: Pfizer vs. Merck

Investors looking for ways to pump up their passive income streams might want to turn their heads toward the pharmaceutical…

3 Fabulous Dividend Stocks to Buy in February

February is the shortest month, but that doesnt mean income investors dont have much time to find great stocks. Three…

Amgen SVP Nancy Grygiel sells stock for $483,807 By Investing.com

Amgen SVP Nancy Grygiel sells stock for $483,807…

The Zacks Analyst Blog Highlights Amgen, CRISPR, Moderna, Sarepta and Vertex

Amgen, CRISPR, Moderna, Sarepta and Vertex are included in this Analyst Blog.…

GNW-News: Accumulus Synergy liefert das erste digital erstellte Dossier der Branche in fast zwei Dutzend Länder gleichzeitig

^BURLINGAME, Kalifornien, Feb. 05, 2025 (GLOBE NEWSWIRE) Accumulus Synergy(?Accumulus") hat in einem branchenweit einmaligen Moment den bahnbrechendenZulassungsantrag von Amgen…

Amgen schlägt die Erwartungen – Adipositas-Rückschlag belastet

Die Berichtssaison läuft weiter auf Hochtouren. Am Dienstag nach US-Börsenschluss hat auch der Biotech-Gigant Amgen die Zahlen für das abgelaufene…

Amgen (AMGN) Q4 2024 Earnings Call Transcript

AMGN earnings call for the period ending December 31, 2024.…

Compared to Estimates, Amgen (AMGN) Q4 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Amgen (AMGN) give a sense of how the business performed in the quarter…

Amgen (AMGN) Q4 Earnings and Revenues Surpass Estimates

Amgen (AMGN) delivered earnings and revenue surprises of 5.57% and 2.54%, respectively, for the quarter ended December 2024. Do the…

Amgen überrascht positiv mit Quartal und Prognose - Kurs dennoch unter Druck

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen blickt nach einem überraschend gut verlaufenen Quartal optimistisch in die Zukunft. 2025…

Amgen überrascht positiv mit Quartal und Prognose - Kurs dennoch unter Druck

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen blickt nach einem überraschend gut verlaufenen Quartal optimistisch…

Amgen profit beats estimates, next MariTide studies start by mid-year

Amgen posted a higher quarterly profit on Tuesday, driven by an 11% rise in product sales, and said late-stage studies…

Amgen profit beats estimates, next MariTide studies start by mid-year By Reuters

Amgen profit beats estimates, next MariTide studies start by mid-year…

These Were the 5 Top-Performing Stocks in the Dow Jones Industrial Average in January 2025

The Dow Jones Industrial Average got off to a solid start this year. The widely reported index, consisting of 30…

The Zacks Analyst Blog Highlights Merck, Pfizer, Eli Lilly, Amgen and Bristol Myers Squibb

Merck, Pfizer, Eli Lilly, Amgen and Bristol Myers Squibb are included in this Analyst Blog.…

EUROPÄISCHE KOMMISSION GENEHMIGT BLINCYTO® BEI PHILADELPHIA-CHROMOSOM-NEGATIVER CD19-POSITIVER B-ZELL-VORLÄUFER-AKUTER LYMPHOBLASTISCHER LEUKÄMIE IN DER KONSOLIDIERUNGSPHASE

Amgen: Thousand Oaks, Kalifornien. (ots/PRNewswire) - BLINCYTO wurde zusätzlich zu einer mehrphasigen konsolidierenden Chemotherapie eingesetzt und senkte das Sterberisiko im…

dpa-AFX ProFeed